Skip to main content
Clinical Trials/JPRN-UMIN000023044
JPRN-UMIN000023044
Completed
未知

The efficacy and safety in canaglifrozin therapy for diabetes complicated by non-alcoholic fatty liver disease. - The efficacy of Canaglifrozin for NAFLD.

Kyoto prefetural University of Medicine0 sites20 target enrollmentOctober 21, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
onalcoholic fatty liver disease type 2 diabetes mellitus
Sponsor
Kyoto prefetural University of Medicine
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 21, 2016
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kyoto prefetural University of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • administration of SGLT2 inhibitors type 1 diabetes platelet count\<100000/microL eGFR\<45m/min/1\.73m2 diagnosed heart failure or malignancy

Outcomes

Primary Outcomes

Not specified

Similar Trials